Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome (2006)

  • Authors:
  • USP affiliated authors: KALIL FILHO, JORGE ELIAS - FM
  • USP Schools: FM
  • DOI: 10.1093/rheumatology/kel118
  • Subjects: INFECÇÕES ESTREPTOCÓCICAS; MIOCARDITE
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Rheumatology
    • ISSN: 1462-0324
    • Volume/Número/Paginação/Ano: v. 45, n. 7, p. 833-841, july 2006
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1093/rheumatology/kel118 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: bronze
    Informações sobre o Citescore
  • Título: Rheumatology

    ISSN: 1462-0324

    Citescore - 2017: 3.59

    SJR - 2017: 2.344

    SNIP - 2017: 1.562


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM10700090333-SFM BCBIB
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BLANK, M.; KRAUSE, I.; MAGRINI, L.; et al. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology, London, v. 45, n. 7, p. 833-841, 2006. DOI: 10.1093/rheumatology/kel118.
    • APA

      Blank, M., Krause, I., Magrini, L., Spina, G., Kalil Filho, J. E., Jacobsen, S., et al. (2006). Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology, 45( 7), 833-841. doi:10.1093/rheumatology/kel118
    • NLM

      Blank M, Krause I, Magrini L, Spina G, Kalil Filho JE, Jacobsen S, Thiesen HJ, Cunningham MW, Guilherme L, Shoenfeld Y. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology. 2006 ; 45( 7): 833-841.
    • Vancouver

      Blank M, Krause I, Magrini L, Spina G, Kalil Filho JE, Jacobsen S, Thiesen HJ, Cunningham MW, Guilherme L, Shoenfeld Y. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology. 2006 ; 45( 7): 833-841.

    Referências citadas na obra
    Guilherme L, Kalil J. Rheumatic fever: from sore throat to autoimmune heart lesions. Int Arch Allergy Immunol2004;134:56–64.
    Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA1992;268:2069–73.
    Sargent SJ, Beachey EH, Corbett CE, Dale JB. Sequence of protective epitopes of streptococcal M proteins shared with cardiac sarcolemmal membranes. J Immunol1987;139:1285–90.
    Dale JB, Beachey EH. Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med1985;161:113–22.
    Cunningham MW. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front Biosci2003;8:s533–43.
    Fenderson PG, Fischetti VA, Cunningham MW. Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol1989;142:2475–81.
    Dale JB, Beachey EH. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med1985;162:583–91.
    Krisher K, Cunningham MW. Myosin: a link between streptococci and heart. Science1985;227:413–5.
    Shikhman AR, Greenspan NS, Cunningham MW. A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M proteins recognizes N-acetyl-beta-D-glucosamine. J Immunol1993;151:3902–13.
    Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest2000;106:217–24.
    Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med2003;9:914–20.
    Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey EH, Dale JB. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol1989;143:2677–83.
    Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med2002;346:752–63.
    Shoenfeld Y. Systemic antiphospholipid syndrome. Lupus2003;12:497–8.
    Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum2002;46:1019–27.
    Cervera R, Khamashta MA, Font J et al. High prevalence of significant heart valve lesions in patients with the ‘primary' antiphospholipid syndrome. Lupus1991;1:43–7.
    Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman–Sacks endocarditis) in the antiphospholipid syndrome. Circulation1996;93:1579–87.
    Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med1924;33:701–37.
    Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol1986;13:486–9.
    Schwarzenbacher R, Zeth K, Diederichs K et al. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. Embo J1999;18:6228–39.
    Bouma B, de Groot PG, van den Elsen JM et al. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J1999;18:5166–74.
    Koike T, Ichikawa K, Atsumi T, Kasahara H, Matsuura E. Beta 2-glycoprotein I-anti-beta 2-glycoprotein I interaction. J Autoimmun2000;15:97–100.
    Brighton TA, Hogg PJ, Dai YP, Murray BH, Chong BH, Chesterman CN. Beta 2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant. Br J Haematol1996;93:185–94.
    Manfredi AA, Rovere P, Heltai S et al. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I. Arthritis Rheum1998;41:215–23.
    Balasubramanian K, Schroit AJ. Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. J Biol Chem1998;273:29272–7.
    Gharavi AE, Sammaritano LR, Wen J, Elkon KB. Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). J Clin Invest1992;90:1105–9.
    Pierangeli SS, Harris EN. Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone. Clin Exp Immunol1993;93:269–72.
    Blank M, Faden D, Tincani A et al. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun1994;7:441–55.
    Gharavi AE, Pierangeli SS, Espinola RG, Liu X, Colden Stanfield M, Harris EN. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum2002;46:545–52.
    Blank M, Krause I, Fridkin M et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest2002;109:797–804.
    Amital H, Langevitz P, Levy Y et al. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. Clin Exp Rheumatol1999;17:99–102.
    Ziporen L, Goldberg I, Arad M et al. Libman–Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus1996;5:196–205.
    Lev S, Shoenfeld Y. Cardiac valvulopathy in the antiphospholipid syndrome. Clin Rev Allergy Immunol2002;23:341–8.
    Cervera R. Recent advances in antiphospholipid antibody-related valvulopathies. J Autoimmun2000;15:123–5.
    Raschi E, Testoni C, Bosisio D et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood2003;101:3495–500.
    Shapiro RF, Gamble CN, Wiesner KB et al. Immunopathogenesis of Libman–Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients. Ann Rheum Dis1977;36:508–16.
    Katzav A, Chapman J, Shoenfeld Y. CNS dysfunction in the antiphospholipid syndrome. Lupus2003;12:903–7.
    Chapman J, Rand JH, Brey RL et al. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus2003;12:514–7.
    Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum1999;42:1309–11.
    Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci USA1999;96:5164–8.
    Adderson EE, Shikhman AR, Ward KE, Cunningham MW. Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: human anti-N-acetylglucosamine/anti-myosin antibody V region genes. J Immunol1998;161:2020–31.
    Arai T, Yoshida K, Kaburaki J et al. Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site. Blood2001;98:1889–96.
    Hong DP, Hagihara Y, Kato H, Goto Y. Flexible loop of beta 2-glycoprotein I domain V specifically interacts with hydrophobic ligands. Biochemistry2001;40:8092–100.
    Guilherme L, Cunha Neto E, Coelho V et al. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation1995;92:415–20.
    Fae K, Kalil J, Toubert A, Guilherme L. Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern. Mol Immunol2004;40:1129–35.
    Amigo MC, Martinez Lavin M, Reyes PA. Acute rheumatic fever. Rheum Dis Clin North Am1993;19:333–50.
    Ayoub EM, Kaplan E. Host-parasite interaction in the pathogenesis of rheumatic fever. J Rheumatol Suppl1991;30:6–13.
    Badr Eldin MK. Solving the problem of the pathogenesis of rheumatic fever. Ann Trop Paediatr1996;16:113–21.
    Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med1991;325:783–93.
    Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev2000;13:470–511.
    Gibofsky A, Kerwar S, Zabriskie JB. Rheumatic fever. The relationships between host, microbe, and genetics. Rheum Dis Clin North Am1998;24:237–59.
    Blank M, Asherson RA, Cervera R, Shoenfeld Y. Antiphospholipid syndrome infectious origin. J Clin Immunol2004;24:12–23.
    Blank M, Shani A, Goldberg I et al. Libman–Sacks endocarditis associated with antiphospholipid syndrome and infection. Thromb Res2004;114:589–92.
    Ardiles L, Ramirez P, Moya P, Caorsi I, Mezzano S. Anticardiolipin antibodies in acute post-streptococcal glomerulonephritis and streptococcal impetigo. Nephron1999;83:47–52.
    Tamura N, Kobayashi S, Hashimoto H. Anticardiolipin antibodies in patients with post-streptococcal reactive arthritis. Ann Rheum Dis2002;61: 374.
    Cunningham MW, Swerlick RA. Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity. J Exp Med1986;164:998–1012.
    Figueroa F, Berrios X, Gutierrez M et al. Anticardiolipin antibodies in acute rheumatic fever. J Rheumatol1992;19:1175–80.
    Ilarraza H, Marquez MF, Alcocer A, Banales JL, Nava AH, Reyes PA. Anticardiolipin antibodies are not associated with rheumatic heart disease. Lupus2001;10:873–5.
    Narin N, Kutukculer N, Narin F, Keser G, Doganavsargil E. Anticardiolipin antibodies in acute rheumatic fever and chronic rheumatic heart disease: is there a significant association? Clin Exp Rheumatol1996;14:567–9.
    Diniz RE, Goldenberg J, Andrade LE et al. Antiphospholipid antibodies in rheumatic fever chorea. J Rheumatol1994;21:1367–8.
    Asherson RA, Hughes GR, Gledhill R, Quinn NP. Absence of antibodies to cardiolipin in patients with Huntington's chorea, Sydenhams chorea and acute rheumatic fever. J Neurol Neurosurg Psychiatry1988;51: 1458.
    Stollerman GH. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol1991;61:131–42.
    Roberts S, Kosanke S, Terrence Dunn S, Jankelow D, Duran CM, Cunningham MW. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis2001;183:507–11.
    Gharavi AE, Pierangeli SS, Colden Stanfield M, Liu XW, Espinola RG, Harris EN. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro. J Immunol1999;163:2922–7.
    George J, Blank M, Levy Y et al. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation1998;97:900–6.
    Del Papa N, Guidali L, Spatola L et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol1995;13:179–85.
    Zhang J, McCrae KR. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood2005;105:1964–9.